Volume 140A, Issue 4 p. 412
Correspondence
Full Access

Response to Feingold's: The use of inappropriate, demeaning, and perjorative terminology to describe syndromes

Robert A. Saul

Corresponding Author

Robert A. Saul

Greenwood Genetic Center, Greenwood, South Carolina

Greenwood Genetic Center, 101 Gregor Mendel Circle, Greenwood, SC 29646.Search for more papers by this author
Harold A. Taylor

Harold A. Taylor

Greenwood Genetic Center, Greenwood, South Carolina

Search for more papers by this author
Jules Leroy

Jules Leroy

Greenwood Genetic Center, Greenwood, South Carolina

Search for more papers by this author
Jurgen Spranger

Jurgen Spranger

Greenwood Genetic Center, Greenwood, South Carolina

Search for more papers by this author
Virginia Proud

Virginia Proud

Children's Hospital of The King's Daughters, Norfolk, Virginia

Search for more papers by this author
First published: 17 January 2006

We agree with Dr. Feingold that the term “Pacman dysplasia” is an inappropriate term for the disease state described in the articles cited due to its insensitive tone [Saul et al., 2005; Wilcox et al., 2005; Feingold, 2006]. The disorder was originally so named based on large osteoclasts consistent with elevated bone resorption by bone marrow histology. The suggested designation “Pacman dysplasia” was then based on the video game in which little round figures consume dots [Shohat et al., 1993; Wilcox et al., 1998]. The nosological lexicon would be better served with a more precise histologic term or a biochemical designation. While we await more cases and possible gene delineation, we now know that at least one cause of this lethal skeletal dysplasia is a prenatal manifestation of mucolipidosis type II [Saul et al., 2005].

We share in the call to eliminate terms for disease description that have negative connotations for families and/or lack the precision needed for syndrome identification.

    The full text of this article hosted at iucr.org is unavailable due to technical difficulties.